Thursday, June 08, 2006

Approval granted for Harvard Stem Cell Institute researchers to attempt creation of disease-specific embryonic stem cell lines





After more than two years of intensive ethical and scientific review, Harvard Stem Cell Institute (HSCI) researchers at Harvard and Children's Hospital Boston have been cleared to begin experiments using Somatic Cell Nuclear Transfer (SCNT) to create disease-specific stem cell lines in an effort to develop treatments for a wide range of now-incurable conditions afflicting tens of millions of people.

(Via Science Blog.)

No comments: